Strategies of drug companies to optimize the sales of their psychiatric drugs
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-12-01
|
| Series: | BMC Psychiatry |
| id |
doaj-55eb7e8d27d5437ab7cb9ec6b4e3c116 |
|---|---|
| record_format |
Article |
| spelling |
doaj-55eb7e8d27d5437ab7cb9ec6b4e3c1162020-11-25T02:34:00ZengBMCBMC Psychiatry1471-244X2007-12-017Suppl 1S9010.1186/1471-244X-7-S1-S90Strategies of drug companies to optimize the sales of their psychiatric drugsWhitaker Robert |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Whitaker Robert |
| spellingShingle |
Whitaker Robert Strategies of drug companies to optimize the sales of their psychiatric drugs BMC Psychiatry |
| author_facet |
Whitaker Robert |
| author_sort |
Whitaker Robert |
| title |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
| title_short |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
| title_full |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
| title_fullStr |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
| title_full_unstemmed |
Strategies of drug companies to optimize the sales of their psychiatric drugs |
| title_sort |
strategies of drug companies to optimize the sales of their psychiatric drugs |
| publisher |
BMC |
| series |
BMC Psychiatry |
| issn |
1471-244X |
| publishDate |
2007-12-01 |
| work_keys_str_mv |
AT whitakerrobert strategiesofdrugcompaniestooptimizethesalesoftheirpsychiatricdrugs |
| _version_ |
1724810879423217664 |